In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Operation OPSS has a list substances prohibited by the DoD. These are substances that FDA, DEA, or the U.S. Armed Services have disallowed, including ones found in products labeled as dietary In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking The Peptide Split: How GLP 1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC 157, TB 500, MOTS c, and the Wellness Grift Borrow Their Halo RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals FDA takes first step in possible reversal of ban on some peptides The Washington Post